Gioia Stefania, Riggio Oliviero, Nardelli Silvia, d'Amati Giulia, Ridola Lorenzo
Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy.
Department of Radiological, Oncological, and Pathological Sciences, Sapienza University of Rome, Rome, Italy.
Hepat Med. 2021 Nov 3;13:105-111. doi: 10.2147/HMER.S282674. eCollection 2021.
The term porto-sinusoidal vascular disease (PSVD) has been recently proposed to replace the term idiopathic non-cirrhotic portal hypertension (INCPH) to describe patients with or without signs of portal hypertension and typical histological lesions involving the portal venules or sinusoids in the absence of cirrhosis. According to the new definition, the presence of known causes of liver disease as well as of portal vein thrombosis does not rule out PSVD. Therefore, the patients in whom the diagnosis of PSVD is possible are much more than the patients strictly fulfilling the diagnostic criteria for INCPH. In this setting, the clinical challenge for the hepatologist is to identify patients at risk of developing PSVD and to indicate liver biopsy to confirm the diagnosis. We describe some possible scenarios in which PSVD should always be suspected, and we provide some tools useful to reach the diagnosis of PSVD.
最近有人提议用“门静脉窦状隙血管疾病(PSVD)”这一术语取代“特发性非肝硬化门静脉高压(INCPH)”,以描述有无门静脉高压体征且在无肝硬化情况下伴有累及门静脉小支或肝血窦典型组织学病变的患者。根据新定义,存在已知肝脏疾病病因以及门静脉血栓形成并不排除PSVD。因此,可能诊断为PSVD的患者比严格符合INCPH诊断标准的患者要多得多。在这种情况下,肝病学家面临的临床挑战是识别有发生PSVD风险的患者,并建议进行肝活检以确诊。我们描述了一些应始终怀疑PSVD的可能情况,并提供了一些有助于诊断PSVD的方法。